MetLife Investment Management’s Imperva, Inc. IMPV Stock Holding History

MetLife Investment Management’s Portfolio IMPV Stock Details IMPV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-15,746	Closed	-$877K	–	2638
2018 Q4	$877K	Hold	15,746	–	–	0.01%	1072
2018 Q3	$731K	Hold	15,746	–	–	0.01%	1295
2018 Q2	$760K	Hold	15,746	–	–	0.01%	1158
2018 Q1	$682K	Hold	15,746	–	–	0.01%	1190
2017 Q4	$625K	Buy	+15,746	New	+$656K	0.01%	1273

MetLife Investment Management's IMPV Position: Q1 2019 in Review

MetLife Investment Management sold out of Imperva, Inc. (IMPV) in Q1 2019, closing a stake of 15,746 shares — an estimated $877K sold.

MetLife Investment Management first reported a position in IMPV in Q4 2017 and held it in 5 quarters. The position peaked at $877K in Q4 2018. 0 funds tracked by Wall St. Rank hold IMPV as of Q1 2019.

MetLife Investment Management reported no remaining Imperva, Inc. position as of Q1 2019 after selling out during the quarter.
MetLife Investment Management sold 15,746 Imperva, Inc. shares in Q1 2019, an estimated $877K.
MetLife Investment Management first reported a position in Imperva, Inc. in Q4 2017 and held it in 5 quarters.
MetLife Investment Management's Imperva, Inc. position peaked at $877K in Q4 2018.
0 funds tracked by Wall St. Rank held Imperva, Inc. as of Q1 2019.

Based on MetLife Investment Management's 13F filing for Q1 2019, filed 15 May 2019.